These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 33568094

  • 1. A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.
    Li J, Xue M, Yan S, Guan C, Xie R, Chen B.
    BMC Infect Dis; 2021 Feb 10; 21(1):165. PubMed ID: 33568094
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of Acquired Immune Deficiency Syndrome Related Primary Central Nervous System Lymphoma from Cerebral toxoplasmosis with Use of Susceptibility-Weighted Imaging and Contrast Enhanced 3D-T1WI.
    Li J, Xue M, Lv Z, Guan C, Huang S, Li S, Liang B, Zhou X, Chen B, Xie R.
    Int J Infect Dis; 2021 Dec 10; 113():251-258. PubMed ID: 34670145
    [Abstract] [Full Text] [Related]

  • 3. Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.
    Kickingereder P, Wiestler B, Sahm F, Heiland S, Roethke M, Schlemmer HP, Wick W, Bendszus M, Radbruch A.
    Radiology; 2014 Sep 10; 272(3):843-50. PubMed ID: 24814181
    [Abstract] [Full Text] [Related]

  • 4. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
    Furtner J, Schöpf V, Preusser M, Asenbaum U, Woitek R, Wöhrer A, Hainfellner JA, Wolfsberger S, Prayer D.
    Eur J Radiol; 2014 May 10; 83(5):806-10. PubMed ID: 24613549
    [Abstract] [Full Text] [Related]

  • 5. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J, Kumar Gupta P, Awasthi A, Pandey CM, Singh A, Patir R, Ahlawat S, Sadashiva N, Mahadevan A, Kumar Gupta R.
    Clin Radiol; 2018 Nov 10; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [Abstract] [Full Text] [Related]

  • 6. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging.
    Radbruch A, Wiestler B, Kramp L, Lutz K, Bäumer P, Weiler M, Roethke M, Sahm F, Schlemmer HP, Wick W, Heiland S, Bendszus M.
    Eur J Radiol; 2013 Mar 10; 82(3):552-6. PubMed ID: 23238364
    [Abstract] [Full Text] [Related]

  • 7. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
    Choi YS, Lee HJ, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK.
    Eur Radiol; 2017 Apr 10; 27(4):1344-1351. PubMed ID: 27436023
    [Abstract] [Full Text] [Related]

  • 8. Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging.
    Ozturk K, Soylu E, Cayci Z.
    Eur J Radiol; 2021 Aug 10; 141():109784. PubMed ID: 34051685
    [Abstract] [Full Text] [Related]

  • 9. 18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI.
    Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B, Geng D, Guan Y.
    Eur J Radiol; 2018 Jul 10; 104():26-32. PubMed ID: 29857862
    [Abstract] [Full Text] [Related]

  • 10. Pretreatment intratumoral susceptibility signals correlate with response to high-dose methotrexate and progression-free survival in primary central nervous system lymphoma.
    Deguchi S, Nakashima K, Muramatsu K, Mitsuya K, Oishi T, Shirata K, Hayashi N, Sugino T, Endo M, Nakasu Y.
    J Clin Neurosci; 2019 Nov 10; 69():43-50. PubMed ID: 31427235
    [Abstract] [Full Text] [Related]

  • 11. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB, Kang XW, Wang N, Liu TT, Zhu YQ, Cheng G, Wang K, Li C, Guo F, Yin H.
    Eur J Radiol; 2019 Mar 10; 112():59-64. PubMed ID: 30777220
    [Abstract] [Full Text] [Related]

  • 12. Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.
    Chen T, Jiang B, Zheng Y, She D, Zhang H, Xing Z, Cao D.
    Neuroradiology; 2020 Feb 10; 62(2):175-184. PubMed ID: 31673748
    [Abstract] [Full Text] [Related]

  • 13. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A, Yamasaki F, Ohtaki M, Kajiwara Y, Takeshima Y, Watanabe Y, Takayasu T, Amatya VJ, Akiyama Y, Sugiyama K, Kurisu K.
    Eur J Radiol; 2012 Feb 10; 81(2):339-44. PubMed ID: 21129872
    [Abstract] [Full Text] [Related]

  • 14. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
    Yu Y, Zhang H, Xiao Z, She D, Xing Z, Yang X, Cao D.
    Acta Radiol; 2018 Aug 10; 59(8):980-987. PubMed ID: 29065704
    [Abstract] [Full Text] [Related]

  • 15. Atypical imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas in patients without AIDS.
    Lee HY, Kim HS, Park JW, Baek HJ, Kim SJ, Choi CG.
    AJNR Am J Neuroradiol; 2013 Aug 10; 34(8):1562-7. PubMed ID: 23413244
    [Abstract] [Full Text] [Related]

  • 16. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI.
    Chang SC, Lai PH, Chen WL, Weng HH, Ho JT, Wang JS, Chang CY, Pan HB, Yang CF.
    Clin Imaging; 2002 Aug 10; 26(4):227-36. PubMed ID: 12140151
    [Abstract] [Full Text] [Related]

  • 17. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
    Suh CH, Kim HS, Jung SC, Park JE, Choi CG, Kim SJ.
    J Magn Reson Imaging; 2019 Aug 10; 50(2):560-572. PubMed ID: 30637843
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC, Watkins TW, Kwan GN, Haacke EM.
    J Neuroimaging; 2016 Jul 10; 26(4):383-90. PubMed ID: 27227542
    [Abstract] [Full Text] [Related]

  • 19. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
    Abdel Razek AAK, El-Serougy L, Abdelsalam M, Gaballa G, Talaat M.
    World Neurosurg; 2019 Mar 10; 123():e303-e309. PubMed ID: 30502475
    [Abstract] [Full Text] [Related]

  • 20. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging.
    Ding Y, Xing Z, Liu B, Lin X, Cao D.
    Brain Behav; 2014 Mar 10; 4(6):841-9. PubMed ID: 25365807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.